This is a Moderna news story, published by Yahoo Finance, that relates primarily to Moderna news.
For more Moderna news, you can click here:
more Moderna newsFor more Moderna news, you can click here:
more Moderna newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
COVID international sales. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest vaccine maker news, Total revenue news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
COVID vaccineReuters
•81% Informative
Moderna cut 2024 sales forecast for COVID-19 and respiratory syncytial virus vaccines by up to 25% , or $1 billion .
Company had previously said it expected roughly $4 billion in sales for the year , which was already the lowest figure for annual revenue since it launched its COVID vaccine in late 2020 .
Moderna reported a net loss of $1.3 billion , or $ 3.33 per share, for the second quarter .
VR Score
92
Informative language
97
Neutral language
87
Article tone
formal
Language
English
Language complexity
47
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links